Pfizer testing omicron-specific Covid vaccine
Pfizer announced it started a clinical trial testing an omicron-specific formula of its Covid-19 vaccine. With the vaccinated and boosted already highly protected against hospitalization, the FDA would have to consider if the formula is even needed.